Adverse effect of oth fibrinolysis-affecting drugs, subs

This code indicates a patient experiencing an unintended, harmful reaction to a fibrinolysis-affecting medication, other than anticoagulants or antithrombotic drugs. This adverse effect is occurring during a follow-up visit or during the recovery phase of the initial treatment. The drug was properly administered and taken as prescribed.

Use this code when a patient presents for ongoing management or evaluation of an adverse reaction to a fibrinolytic agent (e.g., streptokinase, urokinase, alteplase) that is not an anticoagulant or antithrombotic. This applies to situations where the initial treatment for the adverse effect has concluded, and the patient is now in a healing or recovery phase. Examples include persistent bleeding, allergic reactions, or organ damage attributed to the drug, being addressed in a subsequent encounter.

• Always sequence this code after the code(s) for the specific manifestation of the adverse effect.
• Ensure the documentation clearly states the drug was properly administered and identifies it as a fibrinolysis-affecting agent (excluding anticoagulants/antithrombotics).
• The "D" seventh character signifies a subsequent encounter, meaning the patient is receiving routine care during the healing or recovery phase.